Return On Assets of Blueprint Medicines Corp from 30 Sep 2015 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Blueprint Medicines Corp quarterly and annual Return On Assets in % history and change rate from 30 Sep 2015 to 31 Mar 2025.
  • Blueprint Medicines Corp Return On Assets for the quarter ending 31 Mar 2025 was -13%, a 51% increase year-over-year.
  • Blueprint Medicines Corp annual Return On Assets for 2024 was -6%, a 87% increase from 2023.
  • Blueprint Medicines Corp annual Return On Assets for 2023 was -45%, a 4.4% decline from 2022.
  • Blueprint Medicines Corp annual Return On Assets for 2022 was -43%, a 0.32% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Blueprint Medicines Corp Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -13% +14% +51% 01 Jan 2025 31 Mar 2025
Q4 2024 -6% +39% +87% 01 Oct 2024 31 Dec 2024
Q3 2024 -11% +35% +75% 01 Jul 2024 30 Sep 2024
Q2 2024 -19% +24% +57% 01 Apr 2024 30 Jun 2024
Q1 2024 -27% +18% +40% 01 Jan 2024 31 Mar 2024
Q4 2023 -45% -2% -4.4% 01 Oct 2023 31 Dec 2023
Q3 2023 -46% +10% +18% 01 Jul 2023 30 Sep 2023
Q2 2023 -43% +12% +22% 01 Apr 2023 30 Jun 2023
Q1 2023 -45% +3% +6.9% 01 Jan 2023 31 Mar 2023
Q4 2022 -43% 0% +0.32% 01 Oct 2022 31 Dec 2022
Q3 2022 -57% -31% -121% 01 Jul 2022 30 Sep 2022
Q2 2022 -55% -76% -363% 01 Apr 2022 30 Jun 2022
Q1 2022 -48% -71% -310% 01 Jan 2022 31 Mar 2022
Q4 2021 -43% -69% -273% 01 Oct 2021 31 Dec 2021
Q3 2021 -26% -59% -177% 01 Jul 2021 30 Sep 2021
Q2 2021 21% +71% 01 Apr 2021 30 Jun 2021
Q1 2021 23% +70% 01 Jan 2021 31 Mar 2021
Q4 2020 25% +75% 01 Oct 2020 31 Dec 2020
Q3 2020 33% +88% 01 Jul 2020 30 Sep 2020
Q2 2020 -50% +5% +8.7% 01 Apr 2020 30 Jun 2020
Q1 2020 -47% -1% -3.3% 01 Jan 2020 31 Mar 2020
Q4 2019 -50% -11% -30% 01 Oct 2019 31 Dec 2019
Q3 2019 -55% -24% -78% 01 Jul 2019 30 Sep 2019
Q2 2019 -54% -27% -97% 01 Apr 2019 30 Jun 2019
Q1 2019 -45% -14% -44% 01 Jan 2019 31 Mar 2019
Q4 2018 -38% -6% -18% 01 Oct 2018 31 Dec 2018
Q3 2018 -31% +3% +9.9% 01 Jul 2018 30 Sep 2018
Q2 2018 -28% +7% +20% 01 Apr 2018 30 Jun 2018
Q1 2018 -31% +7% +18% 01 Jan 2018 31 Mar 2018
Q4 2017 -32% +2% +6% 01 Oct 2017 31 Dec 2017
Q3 2017 -34% +2% +4.9% 01 Jul 2017 30 Sep 2017
Q2 2017 -35% -2% -6.1% 01 Apr 2017 30 Jun 2017
Q1 2017 -38% -9% -32% 01 Jan 2017 31 Mar 2017
Q4 2016 -34% -1% -3.3% 01 Oct 2016 31 Dec 2016
Q3 2016 -36% +5% +12% 01 Jul 2016 30 Sep 2016
Q2 2016 -33% 01 Apr 2016 30 Jun 2016
Q1 2016 -29% 01 Jan 2016 31 Mar 2016
Q4 2015 -33% 01 Oct 2015 31 Dec 2015
Q3 2015 -41% 01 Jul 2015 30 Sep 2015

Blueprint Medicines Corp Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -6% +39% +87% 01 Jan 2024 31 Dec 2024
2023 -45% -2% -4.4% 01 Jan 2023 31 Dec 2023
2022 -43% 0% +0.32% 01 Jan 2022 31 Dec 2022
2021 -43% -69% -273% 01 Jan 2021 31 Dec 2021
2020 25% +75% 01 Jan 2020 31 Dec 2020
2019 -50% -11% -30% 01 Jan 2019 31 Dec 2019
2018 -38% -6% -18% 01 Jan 2018 31 Dec 2018
2017 -32% +2% +6% 01 Jan 2017 31 Dec 2017
2016 -34% -1% -3.3% 01 Jan 2016 31 Dec 2016
2015 -33% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.